MENU
+Compare
RXRX
Stock ticker: NASDAQ
AS OF
May 16 closing price
Price
$4.56
Change
+$0.31 (+7.29%)
Capitalization
1.85B

RXRX Recursion Pharmaceuticals Forecast, Technical & Fundamental Analysis

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more

RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RXRX with price predictions
May 16, 2025

Momentum Indicator for RXRX turns negative, indicating new downward trend

RXRX saw its Momentum Indicator move below the 0 level on May 05, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In of the 76 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for RXRX turned negative on May 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RXRX's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RXRX advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

RXRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.985) is normal, around the industry mean (15.632). P/E Ratio (0.000) is within average values for comparable stocks, (61.690). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.165). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (24.096) is also within normal values, averaging (276.150).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RXRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RXRX is expected to report earnings to fall 28.80% to -35 cents per share on August 12

Recursion Pharmaceuticals RXRX Stock Earnings Reports
Q2'25
Est.
$-0.36
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
The last earnings report on May 05 showed earnings per share of -50 cents, missing the estimate of -49 cents. With 22.73M shares outstanding, the current market capitalization sits at 1.85B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X106446.0100003254.921900
+3.15%
Bitcoin cryptocurrency
TSLA349.987.16
+2.09%
Tesla
SPY594.203.74
+0.63%
SPDR® S&P 500® ETF
AAPL211.26-0.19
-0.09%
Apple
GME28.45-0.18
-0.63%
GameStop Corp

RXRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+7.29%
CRSP - RXRX
72%
Closely correlated
+6.77%
BEAM - RXRX
63%
Loosely correlated
+3.71%
NTLA - RXRX
61%
Loosely correlated
+5.26%
ABSI - RXRX
60%
Loosely correlated
-2.70%
PRME - RXRX
58%
Loosely correlated
+26.19%
More

Groups containing RXRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+7.29%
RXRX
(2 stocks)
81%
Closely correlated
+7.03%